Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women
- PMID: 20175884
- PMCID: PMC2838821
- DOI: 10.1186/1471-2407-10-53
Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women
Abstract
Background: We evaluated two molecular methods of HPV detection and their correlation with cytological and histological diagnosis in a large sample of Greek women.
Methods: All women with liquid-based cytology performed at a University Hospital between 2000 and 2003 were included. The Hybrid Capture 2 (HC2) kit and in house Polymerase Chain Reaction (PCR) were used for HPV DNA detection. Cervical biopsy was performed for women with ASCUS+ cytology, HPV detection, or abnormal colposcopy. Positive (PLR) and negative (NLR) likelihood ratios were calculated for cytology and HPV molecular testing for the prediction of CIN2 and greater histology.
Results: Of the 1270 women evaluated 241 (18.5%) had abnormal cytology. Cytology diagnosed high-grade squamous intraepithelial lesion (HSIL) or invasive carcinoma in 21(1.7%) cases whereas 26 (2%) women had CIN2+ or greater histology. PCR detected HPV in 397/1270 (31.3%) and HC2 in 260/1270 (20.4%) samples. Both molecular tests exhibited high reproducibility (Cohen's kappa value 0.691, 95% CI: 0.664 - 0.718). Positive likelihood ratios (PLR) of 9.4, 3.8 and 3.4 and negative likelihood ratios of 0.13, 0.21, and 0 were noted for >or= LSIL, any positive HC2 or any positive PCR-HPV testing, for predicting CIN2+ histology, respectively. All CIN 3+ lesions harbored high risk oncogenic HPV type infections.
Conclusions: HPV infection was found in a large proportion of this population and was associated with CIN 2/3 lesions and infiltrating carcinomas. Thin prep testing and HPV detection by HC2 or PCR performed very well with regards to identifying high grade lesions in an environment with experienced examiners.
Similar articles
-
High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.J Med Virol. 2016 Jan;88(1):135-43. doi: 10.1002/jmv.24290. Epub 2015 Jun 30. J Med Virol. 2016. PMID: 26129775
-
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Vaccine. 2012. PMID: 23199969 Review.
-
[Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Oct;28(10):964-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2007. PMID: 18399140 Chinese.
-
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).Gynecol Oncol. 2012 Apr;125(1):175-80. doi: 10.1016/j.ygyno.2012.01.002. Epub 2012 Jan 9. Gynecol Oncol. 2012. PMID: 22233689 Clinical Trial.
-
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Vaccine. 2008. PMID: 18847555 Review.
Cited by
-
Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.Pan Afr Med J. 2018 Jun 12;30:110. doi: 10.11604/pamj.2018.30.110.14321. eCollection 2018. Pan Afr Med J. 2018. PMID: 30364362 Free PMC article.
-
Neutrophil/lymphocyte ratio predicts lymph node metastasis in patients with gastric cancer.Am J Transl Res. 2023 Feb 15;15(2):1412-1420. eCollection 2023. Am J Transl Res. 2023. PMID: 36915778 Free PMC article.
-
Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.BMC Infect Dis. 2016 Nov 7;16(1):642. doi: 10.1186/s12879-016-1969-1. BMC Infect Dis. 2016. PMID: 27821079 Free PMC article.
-
Ancillary studies in determining human papillomavirus status of squamous cell carcinoma of the oropharynx: a review.Patholog Res Int. 2011;2011:138469. doi: 10.4061/2011/138469. Epub 2011 Jul 3. Patholog Res Int. 2011. PMID: 21772959 Free PMC article.
-
Performance evaluation of manual and automated (MagNA pure) nucleic acid isolation in HPV detection and genotyping using Roche Linear Array HPV Test.Infect Dis Obstet Gynecol. 2011;2011:931281. doi: 10.1155/2011/931281. Epub 2011 Jul 9. Infect Dis Obstet Gynecol. 2011. PMID: 21785558 Free PMC article.
References
-
- Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796–802. doi: 10.1093/jnci/87.11.796. - DOI - PubMed
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. - DOI - PubMed
-
- Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98(5):303–315. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous